World Mental Health Day: Neurologist explains how inflammation affects mental disorders’ risk

World Mental Health Day: Recognizing the impact of neuroinflammation has led to promising treatment avenues. Scientists are investigating novel strategies that target inflammatory pathways, exploring anti-inflammatory medications and immune-modulating therapies as potential adjunctive treatments for conditions like depression, anxiety, and dementia.

featured-image

World Mental Health Day: Recognizing the impact of neuroinflammation has led to promising treatment avenues. Scientists are investigating novel strategies that target inflammatory pathways, exploring anti-inflammatory medications and immune-modulating therapies as potential adjunctive treatments for conditions like depression, anxiety, and dementia. New Delhi: Neuroinflammation plays a crucial role in the development and progression of various mental disorders.

This term refers to the activation of the brain’s immune cells, primarily microglia and astrocytes, in response to injury, infection, or stress. While neuroinflammation is a natural protective response, chronic or dysregulated inflammation in the brain has been increasingly linked to mental health conditions like depression, anxiety, schizophrenia, and bipolar disorder. Neuroinflammation is also associated with many demyelinating illnesses such as multiple sclerosis, neuromyelitis optical, etc as well as a number of degenerative diseases such as dementia etc.



While talking about the same, Dr. Ritu Jha, Director & HOD – Neurology, Sarvodaya Hospital, Sector-8, Faridabad, said, “In mental disorders, neuroinflammation may disrupt normal brain function by affecting neurotransmitter signalling, neuronal plasticity, and synaptic integrity. For instance, elevated levels of pro-inflammatory cytokines—chemical messengers that promote inflammation—can alter the function of serotonin and dopamine, neurotransmitters associated with mood regulation.

This disruption can contribute to the emotional and cognitive symptoms observed in mental illnesses.” Emerging research suggests that treating neuroinflammation could be a potential therapeutic target for mental health disorders. Anti-inflammatory drugs, lifestyle interventions like diet and exercise, and even psychotherapies designed to reduce stress-induced inflammation are being explored as ways to modulate neuroinflammation and alleviate symptoms.

Understanding the complex relationship between neuroinflammation and mental disorders offers promising new avenues for treatment, moving beyond conventional approaches and highlighting the importance of brain-immune system interactions in mental health. Dr Virupaaksha H S, HOD & Consultant – Department of Psychiatry, Ramaiah Memorial Hospital, said, “Neuroinflammation involves the activation of immune cells in the brain and plays a significant role in the development and progression of various mental health disorders. The complex interplay between the immunity and nervous systems has been noted to have an impact on the course and outcome of mental health conditions like depression, anxiety, and schizophrenia.

Neuroinflammation can be more pronounced in the elderly population which can lead to poor response to treatment. Understanding this relationship is essential, as it opens new possibilities for early detection, targeted interventions, and treatment strategies for mental illnesses.” Research indicates that chronic low-grade inflammation in the brain can significantly disrupt neurotransmitter signalling, impair cognitive function, and contribute to mood disorders.

Various factors, including infections, stress, environmental pollutants, and unhealthy lifestyles can trigger this inflammatory response. Recognizing the impact of neuroinflammation has led to promising treatment avenues. Scientists are investigating novel strategies that target inflammatory pathways, exploring anti-inflammatory medications and immune-modulating therapies as potential adjunctive treatments for conditions like depression, anxiety, and dementia.

Although further studies are necessary to fully elucidate the mechanisms driving the neuroinflammation in mental disorders, this evolving field offers valuable insights into the complex pathophysiology of these conditions and suggests innovative paths for future therapeutic interventions. Dr. Puneet Kant Arora – Consultant and HOD Neurosurgery, Manipal Hospital, Gurugram also shared his take.

“Neuroinflammation, a response of the brain’s immune system to various insults, plays a significant role in the development and progression of mental disorders. In recent years, research has increasingly highlighted the impact of neuroinflammatory processes on conditions such as depression, schizophrenia, bipolar disorder, and anxiety. Neuroinflammation is primarily characterized by the activation of glial cells, particularly microglia, and astrocytes, which release pro-inflammatory cytokines and chemokines.

These molecules, while crucial for the body’s defense, can lead to neurotoxicity and disrupt neural circuits when produced in excess, thereby influencing mental health,” said Dr Arora. One of the primary mechanisms by which neuroinflammation contributes to mental disorders is through altering neurotransmitter systems. Inflammatory cytokines can influence the synthesis, release, and reuptake of neurotransmitters like serotonin, dopamine, and glutamate, which are essential for mood regulation and cognitive function.

For example, elevated levels of cytokines have been linked to reduced serotonin availability, a key factor in depression. Moreover, inflammatory processes can lead to oxidative stress, which further damages neurons and exacerbates symptoms of mental disorders. In addition to altering neurotransmission, neuroinflammation can also affect neuroplasticity.

Pro-inflammatory cytokines are known to impair the function of neurotrophic factors such as brain-derived neurotrophic factor (BDNF), which is essential for neurogenesis and synaptic plasticity. Reduced levels of BDNF have been associated with various psychiatric conditions, as they compromise the brain’s ability to adapt and recover from stress. Emerging evidence also suggests that neuroinflammation may contribute to the development of mental disorders by influencing the blood-brain barrier (BBB).

Chronic inflammation can lead to BBB dysfunction, allowing peripheral immune cells to infiltratee the brain and exacerbate inflammatory responses, creating a vicious cycle that perpetuates mental illness. In conclusion, neuroinflammation plays a critical role in mental disorders by disrupting neurotransmitter systems, impairing neuroplasticity, and compromising the integrity of the BBB. Understanding these mechanisms can pave the way for novel therapeutic approaches that target neuroinflammation, offering hope for improved management of mental health disorders.

Click for more latest Health news . Also get top headlines and latest news from India and around the world at News9..